AI assistant
Sending…
Equillium, Inc. — Director's Dealing 2018
Oct 16, 2018
34270_dirs_2018-10-16_94ee22e0-f249-4da5-9091-4143b31d7f8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Equillium, Inc. (EQ)
CIK: 0001746466
Period of Report: 2018-10-16
Reporting Person: Biocon SA (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-10-16 | Common Stock | A | 228060 | $0.00 | Acquired | 2316134 | Direct |
Footnotes
F1: This shares were acquired pursuant to certain anti-dilution rights for no additional consideration.
More from Equillium, Inc.
Regulatory Filings
2026
May 29
Annual Report
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 15
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 25
Annual Report
2026
Mar 25
Major Shareholding Notification
2026
Mar 20
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Jan 9